Triptolide alters mitochondrial functions

Advances in Experimental Medicine and Biology

Volumn 599, Issue , 2008, Pages 139-146

  Su, Ying ^a   Yang, Shanmin ^a   Xiao, Zhenyu ^a   Wang, Wei ^a   Okunieff, Paul ^a   Zhang, Lurong ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; REACTIVE OXYGEN METABOLITE; TRIPTOLIDE;

ANIMAL CELL; APOPTOSIS; AUTOIMMUNE DISEASE; CANCER CELL; CANCER INHIBITION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; INHIBITION KINETICS; LEWIS CARCINOMA; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL;

TRIPTERYGIUM WILFORDII;

EID: 84934440377     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-71764-7_19     Document Type: Conference Paper

References (24)

1. S. M. Kupchan, W. A. Court, R. G. Dailey Jr., C. J. Gilmore, R. F. Bryan, Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii, J. Am. Chem. Soc. 94(20), 7194-7195 (1972).
2. S. Yang, J. Chen, Z. Guo, X. M. Xu, L. Wang, X. F. Pei, J. Yang, C. B. Underhill, L. Zhang, Triptolide inhibits the growth and metastasis of solid tumors, Mol. Cancer Ther. 2(1), 65-72 (2003).
3. T. Tengchaisri, R. Chawengkirttikul, N. Rachaphaew, V. Reutrakul, R. Sangsuwan, S. Sirisinha, Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters, Cancer Lett. 133(2), 169-175 (1998).
4. Y. S. Wei, I. Adachi, Inhibitory effect of triptolide on colony formation of breast and stomach cancer cell lines, Chung Kuo. Yao. Li. Hsueh. Pao. 12(5), 406-410 (1991).
5. X. Tao, P. E. Lipsky, The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii. Hook. f., Rheum. Dis. Clin. North Amer. 26, 29-50 (2000).
6. X. Tao, J. J. Cush, M. Garret, P. E. Lipsky, A Phase I study of ethyl acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii. Hook. f. in rheumatoid arthritis. J. Rheumatol. 28, 2160-2167 (2001).
7. X. C. Tao, V. Pinyopornpanit, J. Younger, J. J. Cai, Y. Mao, L. Ma, S. Chang, P. E. Lipsky, A Phase I/II double-blind, placebo-controlled trial of an extract of Tripterygium wilfordii. Hook f. shows benefit in patients with rheumatoid arthritis. Abstract, American College of Rheumatology, 65th Ann. Mtg., San Francisco, CA., Nov. 11-17, 2001. Arthritis Rheum. 44(suppl.).
8. J. L. Faul, T. Nishimura, G. J. Berry, G. V. Benson, R. G. Pearl, P. N. Kao, Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats, Am. J. Respir. Crit. Care Med. 162(6), 2252-2258 (2000).
9. G. Krishna, K. Liu, H. Shigemitsu, M. Gao, T. A. Raffin, G. D. Rosen, PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis, Am. J. Pathol. 158(3), 997-1004 (2001).
10. E. W. Chan, S. C. Cheng, F. W. Sin, Y. Xie, Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines, Toxicol. Lett. 122(1), 81-87 (2001).
11. H. Liu, Z. H. Liu, Z. H. Chen, J. W. Yang, L. S. Li, Triptolide: a potent inhibitor of NF-kappa B in Tlymphocytes. Acta Pharmacol. Sin. 21(9), 782-786 (2000).
12. G. Zhao, L. T. Vaszar, D. Qiu, L. Shi, P. N. Kao, Anti-inflammatory effects of triptolide in human bronchial epithelial cells, Am. J. Physiol. Lung Cell Mol. Physiol. 279(5), L958-L966 (2000).
13. B. J. Chen, C. Liu, X. Cui, J. M. Fidler, N. J. Chao, Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion, Transplantation 70 (10), 1442-1447 (2000).
14. D. Qiu, G. Zhao, Y. Aoki, L. Shi, A. Uyei, S. Nazarian, J. C. Ng, P. N. Kao, Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation, J. Biol. Chem. 274(19), 13443-13450 (1999)
15. N. Dias, C. Bailly, Drugs targeting mitochondrial functions to control tumor cell growth, Biochem. Pharmacol. 70(1), 1-12 (2005).
16. R. Kim, Recent advances in understanding the cell death pathways activated by anticancer therapy, Cancer 103(8), 1551-1560 (2005).
17. T. Asakura, K. Ohkawa, Chemotherapeutic agents that induce mitochondrial apoptosis, Curr. Cancer Drug Targets 4(7), 577-590 (2004).
18. T. Tengchaisri, R. Chawengkirttikul, N. Rachaphaew, V. Reutrakul, R. Sangsuwan, S. Sirisinha, Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters, Cancer Lett. 133(2), 169-175 (1998).
19. Y. S. Wei, I. Adachi, Inhibitory effect of triptolide on colony formation of breast and stomach cancer cell lines, Chung Kuo. Yao. Li. Hsueh. Pao. 12(5), 406-410 (1991).
20. J. Y. Xu, J. Yang, L. Z. Li, Antitumor effect of Tripterygium wilfordii, Chung Kuo. Chung His. I. Chieh Ho. Tsa. Chih. 12(3), 161 (1992).
21. W. Z. Gu, S. R. Brandwein, Inhibition of type II collagen-induced arthritis in rats by triptolide, Int. J. Immunopharmacol. 20(8), 389-400 (1998).
22. The Invitrogen online catalog, accessed 6/18/05. http://probes. invitrogen.com/media/publications/508.pdf
23. V. Petronilli, G. Miotto, M. Canton, M. Brini, R. Colonna, P. Bernardi, F. Di Lisa, Transient and longlasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence, Biophys. J. 76(2), 725-734 (1999).
24. V. Petronilli, G. Miotto, M. Canton, R. Colonna, P. Bernardi, F. Di Lisa, Imaging the mitochondrial permeability transition pore in intact cells, Biofactors 8(3-4), 263-272 (1998).